Prolia

Amgen vs. Sandoz: Legal Battle Erupts Over Bone-Strengthening Drug Patents
Amgen vs. Sandoz: Legal Battle Erupts Over Bone-Strengthening Drug Patents
Yahoo/Benzinga
Amgen
Sandoz
legal
Prolia
Xgeva
patents
denosumab
Flag link:
Amgen's denosumab shows promise in small, NIH-funded rare bone disease study
Amgen's denosumab shows promise in small, NIH-funded rare bone disease study
Endpoints
Amgen
Prolia
Xgeva
denosumab
clinical trials
NIH
biosimilars
monoclonal antibodies
Flag link:
Sandoz files biosimilar of Amgen osteoporosis drug in US
Sandoz files biosimilar of Amgen osteoporosis drug in US
Pharmaphorum
Sandoz
Novartis
biosimilars
osteoporosis
Prolia
Xgeva
FDA
Flag link:
The top 15 blockbuster patent expirations coming this decade
The top 15 blockbuster patent expirations coming this decade
Fierce Pharma
patents
patent cliff
AbbVie
Humira
Merck
Keytruda
Bristol Myers Squibb
Revlimid
Pfizer
Eliquis
Regeneron
Eylea
JNJ
Stelara
Opdivo
GSK
Dolutegravir
Ibrance
Januvia
Eli Lilly
Trulicity
Novo Nordisk
Victoza
Amgen
Prolia
Xgeva
Novartis
Cosentyx
Takeda
Entyvio
Flag link:
Sandoz recruits first patient in clinical study for proposed biosimilar denosumab in osteoporosis
Sandoz recruits first patient in clinical study for proposed biosimilar denosumab in osteoporosis
Pharmaceutical Business Review
Novartis
Sandoz
biosimilars
clinical trials
denosumab
osteoporosis
Prolia
Xgeva
Flag link:
Consumer watchdog petitions FDA for black box warning on Amgen's Prolia
Consumer watchdog petitions FDA for black box warning on Amgen's Prolia
Fierce Pharma
FDA
osteoporosis
Amgen
Prolia
spinal fractures
Public Citizen
Flag link:
Will Amgen’s migraine win and 5th thumbs-up for Prolia drive enough growth? Nope, says analyst
Will Amgen’s migraine win and 5th thumbs-up for Prolia drive enough growth? Nope, says analyst
Fierce Pharma
Amgen
FDA
Aimovig
migraines
Prolia
Flag link:
Amgen focuses on migraine launch as growth remains slow
Amgen focuses on migraine launch as growth remains slow
Biopharma Dive
Amgen
earnings
Repatha
Kyprolis
Prolia
Xgeva
Flag link:
What to Expect From Amgen, Inc. in 2018
What to Expect From Amgen, Inc. in 2018
Motley Fool
Amgen
Enbrel
Neulasta
Aranesp
Epogen
Neupogen
Prolia
Repatha
CAR-T
Flag link:
5 Things Amgen's CEO Just Said That Investors Need to Know
5 Things Amgen's CEO Just Said That Investors Need to Know
Motley Fool
Amgen
Pharma CEOs
Bob Bradway
Prolia
M&A
Flag link:
Amgen rolls new Prolia osteoporosis ads, just weeks after next-gen Evenity hits a snag
Amgen rolls new Prolia osteoporosis ads, just weeks after next-gen Evenity hits a snag
Fierce Pharma
Amgen
Prolia
osteoporosis
drug ads
Flag link:
Dr Reddy's and Amgen broaden marketing collaboration
Dr Reddy's and Amgen broaden marketing collaboration
BioPharma Dive
Amgen
Dr Reddy's
India
Xgeva
Prolia
Vectibix
Flag link:
Amgen’s Bone Health Drug Saw Strong Revenue Growth in 2Q16
Amgen’s Bone Health Drug Saw Strong Revenue Growth in 2Q16
Market Realist
Amgen
Prolia
Xgeva
osteoporosis
Flag link:
Can Amgen’s Prolia Continue Its Strong Growth Trajectory in 2016?
Can Amgen’s Prolia Continue Its Strong Growth Trajectory in 2016?
Yahoo/Market Realist
Amgen
Prolia
Flag link:
9 Drugs That Cost Medicare a Fortune
9 Drugs That Cost Medicare a Fortune
Motley Fool
Medicare
Lucentis
Eylea
Prolia
Treanda
Lexiscan
Yervoy
Privigen
Provenge
Soliris
Flag link:
How Could Prolia Drive Amgen’s Valuations in 2016?
How Could Prolia Drive Amgen’s Valuations in 2016?
Yahoo/Market Realist
Prolia
Amgen
Flag link:
Amgen reacquires rights to three drugs from Glaxo in 48 countries
Amgen reacquires rights to three drugs from Glaxo in 48 countries
Yahoo/Reuters
Amgen
GSK
Prolia
Vectibix
Xgeva
Flag link:
Is Amgen's Prolia A Better Drug For Reducing Fractures And Recurrence After Breast Cancer?
Is Amgen's Prolia A Better Drug For Reducing Fractures And Recurrence After Breast Cancer?
Forbes
Amgen
Prolia
breast cancer
Flag link:
Amgen ends marketing agreement with GSK for osteoporosis drug
Amgen ends marketing agreement with GSK for osteoporosis drug
Yahoo/Reuters
Amgen
GSK
osteoporosis
Prolia
Flag link:
Xgeva and Prolia: Setting the Pace for Amgen, Inc.
Xgeva and Prolia: Setting the Pace for Amgen, Inc.
Motley Fool
Xgeva
Prolia
Amgen
Flag link:

Pages